Overview
This symposium will be conducted in Japanese Language.
Click Here to View the Program in Japanese
We've closed online registration.
Onsite resistration is still available.
Program Committee
-
Keiko Tsumori, MSC Associate Principle Scientist, Medical Writing, Regulatory Affairs Area, Japan D
MSD K.K., Japan -
Hiroko Ebina, MBA, RPH Principal Writer I
Proscribe KK - Part of the ENVISION PHARMA GROUP, Japan -
Yuko Kojima, RPH Sr. Executive Director
Eli Lilly Japan K.K., Japan -
Miyoshi Masuda Senior Manager, Medical Writing, Clinical Development Administration
Astellas Pharma Inc., Japan -
Satoru Mogami, MSC Regulatory Affairs
Pfizer R&D Japan, Japan -
Junichi Nishino, MSC, RPH Head, Regulatory Affairs Department
Otsuka Pharmaceutical Co., Ltd., Japan -
Tomoko Okudaira Director of Personnel Coordination, Office of General Affairs
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Naoko Tejima Group Manager, Regulatory Writing & Operations Group, Regulatory Affairs
Astellas Amgen Biopharma, Japan
Have an account?